Nystatin (Fungicidin): Polyene Antifungal Agent for Candida Research

Executive Summary: Nystatin (Fungicidin) is a polyene antifungal antibiotic that disrupts fungal cell membranes by binding ergosterol (APExBIO, product B1993). It exhibits potent inhibition against Candida albicans (MIC₉₀: 4 mg/L) and other Candida species (MIC: 0.39–3.12 μg/mL) under standard laboratory conditions (APExBIO; [Wang et al., 2018](https://doi.org/10.1186/s12985-018-0993-8)). Nystatin reduces fungal adhesion to human epithelial cells but is less effective on C. albicans adhesion compared to non-albicans species ([related analysis](https://amyloid-protein-1-15.com/index.php?g=Wap&m=Article&a=detail&id=71)). Liposomal formulations protect neutropenic mice against Aspergillus at doses ≥2 mg/kg/day ([see below](#evidence-and-benchmarks)). The compound is highly soluble in DMSO (≥30.45 mg/mL), insoluble in water/ethanol, and stable when stored at –20°C. These properties make Nystatin (Fungicidin) a gold-standard reference for antifungal mechanism and resistance studies.

Biological Rationale

Nystatin (Fungicidin) is a member of the polyene class of antifungal antibiotics. It is derived from Streptomyces noursei. The agent’s primary research use is the selective inhibition of yeast and mycoplasma in cell culture and infection models. Its efficacy is established for a wide array of Candida species, including C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei. Nystatin is a critical tool in elucidating mechanisms of fungal pathogenesis, cell membrane biology, and antifungal resistance. Its quantitative potency and selectivity enable rigorous benchmarking of antifungal interventions ([APExBIO](https://www.apexbt.com/nystatin-fungicidin.html)).

Mechanism of Action of Nystatin (Fungicidin)

Nystatin acts by binding directly to ergosterol, the principal sterol in fungal cell membranes. This interaction induces pore formation, which disrupts membrane integrity and increases permeability. The resulting loss of ions and small molecules leads to fungal cell death. This mode of action is highly selective: mammalian cells contain cholesterol, not ergosterol, rendering them less susceptible. The specificity of ergosterol targeting underpins the agent’s utility as a research probe for membrane biology and antifungal resistance ([see advanced review](https://n3-kethoxal.com/index.php?g=Wap&m=Article&a=detail&id=10923) & [APExBIO](https://www.apexbt.com/nystatin-fungicidin.html)).

Evidence & Benchmarks

• Nystatin (Fungicidin) inhibits Candida albicans with a MIC₉₀ of 4 mg/L in standardized media at 35°C (APExBIO, product B1993).
• Other Candida species (C. glabrata, C. parapsilosis, C. tropicalis, C. krusei) display MIC ranges of 0.39–3.12 μg/mL under similar conditions (Amyloid-Protein-1-15.com).
• Nystatin reduces adhesion of Candida species to human buccal epithelial cells, though C. albicans adhesion is less affected (APExBIO data; PHA-793887.com).
• Liposomal Nystatin protects neutropenic mice from Aspergillus infections at dosages ≥2 mg/kg/day, with significant survival benefits in controlled studies (Amyloid-Protein-1-15.com).
• Nystatin does not inhibit clathrin-mediated viral entry in grass carp kidney cells, distinguishing its specificity for sterol-rich fungal membranes ([Wang et al., 2018, DOI:10.1186/s12985-018-0993-8](https://doi.org/10.1186/s12985-018-0993-8)).
• Optimal solubility in DMSO (≥30.45 mg/mL) at room temperature; insoluble in water and ethanol (APExBIO, product documentation).
• Solid state molecular weight: 926.09 g/mol; chemical formula: C₄₇H₇₅NO₁₇ (APExBIO).

Applications, Limits & Misconceptions

Nystatin (Fungicidin) is widely used in research on fungal pathogenesis, antifungal susceptibility, and therapeutic efficacy in murine infection models. It is a standard reference for studying the ergosterol binding mechanism and for benchmarking resistance in non-albicans Candida. Its use in studying vulvovaginal candidiasis and mycoplasma contamination is also well-documented. For a deeper dive into mechanistic exploration, see this article, which extends the discussion to next-generation antifungal strategies not covered here.

Common Pitfalls or Misconceptions

• Nystatin is not active against bacteria or viruses. It is specific to fungi and some mycoplasma; its inactivity in viral entry inhibition is supported by [Wang et al., 2018](https://doi.org/10.1186/s12985-018-0993-8).
• Nystatin is insoluble in water and ethanol. Attempting to dissolve in these solvents leads to precipitation and loss of bioactivity (APExBIO).
• Long-term storage of solutions is not recommended. Use stock solutions promptly; only solid form is stable for months at –20°C (APExBIO).
• Nystatin does not inhibit all fungal species equally. C. albicans adhesion is less affected compared to non-albicans species (APExBIO; Amyloid-Protein-1-15.com).
• It is not effective for treating established viral infections or as a clathrin-mediated endocytosis inhibitor ([Wang et al., 2018](https://doi.org/10.1186/s12985-018-0993-8)).

Workflow Integration & Parameters

For research use, prepare Nystatin (Fungicidin) stock solutions in DMSO at concentrations ≥30.45 mg/mL. Warming and ultrasonic shaking enhance solubility. Store solid compound at –20°C. Use solutions immediately or store below –20°C for up to several months, avoiding repeated freeze–thaw cycles. In antifungal susceptibility assays, typical working concentrations span 0.39–4 mg/L, depending on organism and protocol. For in vivo murine models, liposomal Nystatin is dosed at 2–5 mg/kg/day. Always confirm MIC values against current CLSI/EUCAST standards. For advanced guidance on workflow optimization, this article provides detailed integration strategies, while the present article updates select protocols with recent evidence.

Conclusion & Outlook

Nystatin (Fungicidin) remains a cornerstone polyene antifungal for research on Candida pathogenesis and antifungal resistance. Its ergosterol-targeting mechanism and robust, quantifiable activity against clinically relevant Candida and Aspergillus models continue to support its use as a standard reference. Current research, as curated by APExBIO, highlights the importance of precise workflow parameters to maximize reproducibility and reliability. Ongoing studies into resistance and next-generation delivery formats will further define its role in both basic research and translational antifungal science.